Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 4, Issue 4, Pages 505-524
Publisher
Future Science, LTD
Online
2012-03-15
DOI
10.4155/fmc.12.3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer
- (2012) Charles Marson Anti-Cancer Agents in Medicinal Chemistry
- Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors
- (2011) Lewis Whitehead et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity
- (2011) Sun Ea Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of histone deacetylase 8 selective inhibitors
- (2011) Weiping Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The design, synthesis and structure–activity relationships of novel isoindoline-based histone deacetylase inhibitors
- (2011) Michael Shultz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: Design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors
- (2011) Harish Rajak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
- (2011) A R A Razak et al. BRITISH JOURNAL OF CANCER
- Metabolic Homeostasis: HDACs Take Center Stage
- (2011) Jason Karpac et al. CELL
- Recognition of a Mononucleosomal Histone Modification Pattern by BPTF via Multivalent Interactions
- (2011) Alexander J. Ruthenburg et al. CELL
- CpG island chromatin
- (2011) Neil P. Blackledge et al. Epigenetics
- Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile
- (2011) Haishan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors
- (2011) Michael D. Shultz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Synthesis, and Pharmacological Evaluation of Spiropiperidine Hydroxamic Acid Based Derivatives as Structurally Novel Histone Deacetylase (HDAC) Inhibitors
- (2011) Mario Varasi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis of the Antiproliferative Activity of Largazole, a Depsipeptide Inhibitor of the Histone Deacetylases
- (2011) Kathryn E. Cole et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Involvement of Caveolin in Probucol-Induced Reduction in hERG Plasma-Membrane Expression
- (2011) J. Guo et al. MOLECULAR PHARMACOLOGY
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Novel roles for hERG K+ channels in cell proliferation and apoptosis
- (2011) J Jehle et al. Cell Death & Disease
- Cancer cells’ epigenetic composition and predisposition to histone deacetylase inhibitor sensitization
- (2011) Narasimharao Nalabothula et al. Epigenomics
- Pruritus in Cutaneous T-cell Lymphomas: Frequent, Often Severe and Difficult to Treat
- (2010) N Meyer et al. ACTA DERMATO-VENEREOLOGICA
- Cardiotoxicity
- (2010) I. Brana et al. ANNALS OF ONCOLOGY
- Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors
- (2010) Yingjie Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A Modified Epigenetics Toolbox to Study Histone Modifications on the Nucleosome Core
- (2010) Floor Frederiks et al. CHEMBIOCHEM
- Macrocyclic Histone Deacetylase Inhibitors
- (2010) Sandra C. Mwakwari et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Polymeric drug delivery systems for localized cancer chemotherapy
- (2010) Raquel De Souza et al. DRUG DELIVERY
- 178 Preclinical characterization of 4SC-202, a novel isotype specific HDAC inhibitor
- (2010) S.W. Henning et al. EJC SUPPLEMENTS
- Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells
- (2010) Kevin V. Morris Epigenetics
- Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
- (2010) Cliona Grant et al. Expert Review of Anticancer Therapy
- An overview of epigenetics and chemoprevention
- (2010) Yi-Wen Huang et al. FEBS LETTERS
- Epigenetic therapy: targeting histones and their modifications in human disease
- (2010) Akash Gunjan et al. Future Medicinal Chemistry
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Transcriptional Profiling after Lipid Raft Disruption in Keratinocytes Identifies Critical Mediators of Atopic Dermatitis Pathways
- (2010) Conny Mathay et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Non-Peptide Macrocyclic Histone Deacetylase Inhibitors Derived from Tricyclic Ketolide Skeleton
- (2010) Sandra C. Mwakwari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity
- (2010) Luciana Auzzas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The challenge of modeling nuclear receptor regulatory networks in mammalian cells
- (2010) Vidhya Jagannathan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- The role of transcription factories-mediated interchromosomal contacts in the organization of nuclear architecture
- (2010) Julien Dorier et al. NUCLEIC ACIDS RESEARCH
- Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group
- (2009) Vishal Patil et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide
- (2009) Joshua C. Canzoneri et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia
- (2009) Kristie A. Blum et al. BRITISH JOURNAL OF HAEMATOLOGY
- Isoform-specific histone deacetylase inhibitors: The next step?
- (2009) Sriram Balasubramanian et al. CANCER LETTERS
- Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes
- (2009) Zhibin Wang et al. CELL
- A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer
- (2009) P. N. Munster et al. CLINICAL CANCER RESEARCH
- Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+
- (2009) Dante Rotili et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Distribution Characteristics of Telithromycin, a Novel Ketolide Antimicrobial Agent Applied for Treatment of Respiratory Infection, in Lung Epithelial Lining Fluid and Alveolar Macrophages
- (2009) Kohei Togami et al. Drug Metabolism and Pharmacokinetics
- New patented histone deacetylase inhibitors
- (2009) Haishan Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Approaches to target the genome and its epigenome in cancer
- (2009) Nadine Chapman-Rothe et al. Future Medicinal Chemistry
- Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation
- (2009) Reinhard Brunmeir et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Nonclinical Safety Assessment of the Histone Deacetylase Inhibitor Vorinostat
- (2009) Janet S. Kerr et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Biological Evaluation ofN-Hydroxyphenylacrylamides andN-Hydroxypyridin-2-ylacrylamides as Novel Histone Deacetylase Inhibitors
- (2009) Florian Thaler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma
- (2009) Axel Hauschild et al. MELANOMA RESEARCH
- The logic of chromatin architecture and remodelling at promoters
- (2009) Bradley R. Cairns NATURE
- Genetic dissection of histone deacetylase requirement in tumor cells
- (2009) M. Haberland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- QT interval prolongation among patients treated with angiogenesis inhibitors
- (2009) Stephane Ederhy et al. Targeted Oncology
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases
- (2008) Philip Jones et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Isoform-selective histone deacetylase inhibitors
- (2008) Anton V. Bieliauskas et al. CHEMICAL SOCIETY REVIEWS
- A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas
- (2008) L. Gore et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
- (2008) B. Sadikovic et al. CURRENT GENOMICS
- Non-Invasive Tests in Animal Models and Humans: A New Paradigm for Assessing Efficacy of Biologics Including Prebiotics and Probiotics
- (2008) R. Butler CURRENT PHARMACEUTICAL DESIGN
- Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
- (2008) Robert P. Whitehead et al. INVESTIGATIONAL NEW DRUGS
- Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer
- (2008) Johan Vansteenkiste et al. INVESTIGATIONAL NEW DRUGS
- Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain
- (2008) Matthew J. Bottomley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity
- (2008) Anja Schuetz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma
- (2008) Jennifer A. Woyach et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors
- (2008) Lillian L. Siu et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-Peptide Macrocyclic Histone Deacetylase Inhibitors
- (2008) Adegboyega K. Oyelere et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- From immunity to tolerance through HDAC
- (2008) Katia Georgopoulos NATURE IMMUNOLOGY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
- (2008) Aleksey G. Kazantsev et al. NATURE REVIEWS DRUG DISCOVERY
- Epigenetics of cancer progression
- (2008) Emily A Vucic et al. PHARMACOGENOMICS
- Human ether-a-go-go related gene (hERG) K+ channels: Function and dysfunction
- (2008) Mark J. Perrin et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now